Skip to content

Home
What We Do
Why Choose Us
Publications
About
Contact Us

Andrew Lewis Law

Latest

September 2018

Posted 31/03/2019 News

Advised the investor consortium in relation to their NZ$15m investment in leading medical cannabis start-up, Helius Therapeutics.

Post navigation

⟵Welcome to Andrew Lewis Law

The company or the assets?⟶

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Comment

Name *

Email *

Website

Save my name, email, and website in this browser for the next time I comment.

Home
What We Do
Why Choose Us
Publications
About
Contact Us

Website by

Proudly powered by WordPress | Theme: Sydney by aThemes.